lifestyle.luxedb.com

Author: CARIS MPI, INC., d/b/a CARIS LIFE SCIENCES

Caris Life Sciences Introduces Powerful New Caris AI Insights to Identify Early Platinum Resistance in Ovarian Cancer

March 16, 2026
Caris Life Sciences to Showcase Five Studies at the 2026 USCAP Annual Meeting

March 11, 2026
Caris Life Sciences Launches a Novel Caris AI Insights Signature to Guide First-Line Therapy Selection and Treatment De-Escalation in Pancreatic Cancer

March 9, 2026
/C O R R E C T I O N — Caris Life Sciences/

February 27, 2026
Caris Life Sciences Completes Interim Readout of Achieve 1 Study

February 27, 2026
Caris Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook

February 27, 2026
Caris Launches Proprietary AI Insights Signature Which Deepens Understanding of Response to Breast Cancer Patients’ Oral Chemotherapy Drug

February 24, 2026
Caris Life Sciences to Participate in the TD Cowen 46th Annual Health Care Conference

February 23, 2026
Caris Life Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26

February 12, 2026
Caris Life Sciences’ Real-World Data Uncovers Metastatic Breast Cancer Patient Responses and Resistance to Trastuzumab Deruxtecan

January 28, 2026